Pulvinal inhalers discontinued

Pulvinal Beclometasone and Pulvinal Salbutamol dry powder inhalers have been discontinued following a decline in demand.

Stocks of Pulvinal Beclometasone 100, 200 and 400 microgram are expected to run out by the end of 2015. A limited supply of Pulvinal Salbutamol will be available until the middle of January 2016.

Further information
Manufacturer: Chiesi

Healthcare professionals should identify patients currently using these devices and discuss alternatives as soon as possible.

For a guide to available inhalers for the treatment of asthma and COPD, see the asthma and COPD preparations and compatible devices table and the guide to breath-actuated inhalers.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Two new steroid inhalers launched

Two new steroid inhalers launched

A new beclometasone metered-dose inhaler and a new...

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients prescribed statins fail to reach their...

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

The SGLT2 inhibitor dapagliflozin (Forxiga) can now...

Quick-reference MIMS COPD prescribing resources updated

Quick-reference MIMS COPD prescribing resources updated

Concise MIMS resources on COPD management and antibiotic...